These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 7692448)

  • 1. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.
    Yang Y; Janich S; Cohn JA; Wilson JM
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9480-4. PubMed ID: 7692448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP.
    Lukacs GL; Mohamed A; Kartner N; Chang XB; Riordan JR; Grinstein S
    EMBO J; 1994 Dec; 13(24):6076-86. PubMed ID: 7529176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator.
    Pind S; Riordan JR; Williams DB
    J Biol Chem; 1994 Apr; 269(17):12784-8. PubMed ID: 7513695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calnexin Delta 185-520 partially reverses the misprocessing of the Delta F508 cystic fibrosis transmembrane conductance regulator.
    Okiyoneda T; Wada I; Jono H; Shuto T; Yoshitake K; Nakano N; Nagayama S; Harada K; Isohama Y; Miyata T; Kai H
    FEBS Lett; 2002 Aug; 526(1-3):87-92. PubMed ID: 12208510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70.
    Farinha CM; Nogueira P; Mendes F; Penque D; Amaral MD
    Biochem J; 2002 Sep; 366(Pt 3):797-806. PubMed ID: 12069690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
    Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
    Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator.
    Zhang XM; Wang XT; Yue H; Leung SW; Thibodeau PH; Thomas PJ; Guggino SE
    J Biol Chem; 2003 Dec; 278(51):51232-42. PubMed ID: 14532265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous expression of delta F508 CFTR results in decreased sialylation of membrane glycoconjugates.
    Dosanjh A; Lencer W; Brown D; Ausiello DA; Stow JL
    Am J Physiol; 1994 Feb; 266(2 Pt 1):C360-6. PubMed ID: 7511336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.
    Yang H; Shelat AA; Guy RK; Gopinath VS; Ma T; Du K; Lukacs GL; Taddei A; Folli C; Pedemonte N; Galietta LJ; Verkman AS
    J Biol Chem; 2003 Sep; 278(37):35079-85. PubMed ID: 12832418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR.
    Zhang F; Kartner N; Lukacs GL
    Nat Struct Biol; 1998 Mar; 5(3):180-3. PubMed ID: 9501909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant (delta F508) cystic fibrosis transmembrane conductance regulator Cl- channel is functional when retained in endoplasmic reticulum of mammalian cells.
    Pasyk EA; Foskett JK
    J Biol Chem; 1995 May; 270(21):12347-50. PubMed ID: 7539001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression.
    Okiyoneda T; Harada K; Takeya M; Yamahira K; Wada I; Shuto T; Suico MA; Hashimoto Y; Kai H
    Mol Biol Cell; 2004 Feb; 15(2):563-74. PubMed ID: 14595111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural localization of variant forms of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial of xenografts.
    Yang Y; Engelhardt JF; Wilson JM
    Am J Respir Cell Mol Biol; 1994 Jul; 11(1):7-15. PubMed ID: 7517144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.
    Rubenstein RC; Egan ME; Zeitlin PL
    J Clin Invest; 1997 Nov; 100(10):2457-65. PubMed ID: 9366560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.
    Teem JL; Berger HA; Ostedgaard LS; Rich DP; Tsui LC; Welsh MJ
    Cell; 1993 Apr; 73(2):335-46. PubMed ID: 7682896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins.
    Ward CL; Kopito RR
    J Biol Chem; 1994 Oct; 269(41):25710-8. PubMed ID: 7523390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered biogenesis of deltaF508-CFTR following treatment with doxorubicin.
    Maitra R; Hamilton JW
    Cell Physiol Biochem; 2007; 20(5):465-72. PubMed ID: 17762173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR.
    Li C; Ramjeesingh M; Reyes E; Jensen T; Chang X; Rommens JM; Bear CE
    Nat Genet; 1993 Apr; 3(4):311-6. PubMed ID: 7526932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression.
    Cheng SH; Fang SL; Zabner J; Marshall J; Piraino S; Schiavi SC; Jefferson DM; Welsh MJ; Smith AE
    Am J Physiol; 1995 Apr; 268(4 Pt 1):L615-24. PubMed ID: 7733303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traffic pattern of cystic fibrosis transmembrane regulator through the early exocytic pathway.
    Bannykh SI; Bannykh GI; Fish KN; Moyer BD; Riordan JR; Balch WE
    Traffic; 2000 Nov; 1(11):852-70. PubMed ID: 11208075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.